In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Electronic anti-theft systems remain a threat to cardiac device patients

Today’s systems are often hidden by advertising, or buried under floors, in walls or in doors

Device Complications
Atrial Fibrillation

Embargoed: 09:00 hrs (CEST) Wednesday 8 June 2016

Nice, France – 8 June 2016: Electronic anti-theft systems still post a threat to cardiac device patients, according to research presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Professor Robert Stevenson, senior scientist at Greatbatch Medical in Santa Clarita, California, US.1

“Cardiac implantable electronic devices (CIEDs) are critical to patients’ health,” said co-author Dr Rod Gimbel, an electrophysiologist at Case Western Reserve University in Cleveland, Ohio, US. “Pacemakers provide pacing support, without which there would be no heart beat at all for a pacemaker dependent patient. Implantable cardioverter defibrillators (ICDs) deliver pacing or shocks to rescue patients from potentially life threatening arrhythmias.”

Even though reported events are rare, prolonged exposure to electronic anti-theft systems, also called electronic article surveillance (EAS) systems, can cause pacing therapy to drop beats or in the worst case leave pacemaker dependent patients with no heart beat, and cause ICDs to deliver inappropriate shocks. In 2000 the US Food and Drug Administration (FDA) advised CIED patients not to linger or lean next to EAS systems. But since then manufacturers have created sleeves for retailers to cover traditional pedestal systems with advertising and new systems are hidden under floors, in walls and in doors.

Dr Gimbel said: “We tell patients ‘don’t linger, don’t lean’ but that advice is hard to follow when systems are invisible. To make matters worse, advertising draws patients closer to the pedestals. Some shops have placed camouflaged pedestals next to a chair or in a checkout line, so patients may be next to them for some time, and sofas are put on top of under floor systems, encouraging patients to sit for long periods.”

The current study was conducted at Georgia Tech Research Institute (GTRI) in Atlanta and assessed the safety of modern EAS systems. The investigators tested pacemakers and ICDs with up to five CIED manufacturers against the three types of EAS systems currently in use: pedestals (five manufacturers), door frames/in wall (two manufacturers) and under floor (two manufacturers). The under floor system was tested flat and at a 30 degree angle to mimic slouching in a chair. The results were recorded in four categories: no interference, prolonged pacemaker inhibition, inappropriate shocks, and other inappropriate tachycardia therapy such as anti-tachycardia pacing or subclinical shocks.

The tests were conducted with the pacemakers and ICDs in a tank filled with a type of saline that mimics the electric properties of body tissue. Cardiac device leads were placed in the same loop shape as they would be in a patient and the devices were tested in unipolar and bipolar settings.2 The distance between devices and the floor was set for average height patient. Devices were tested in static positions and using a robot to simulate a patient walking through the EAS systems, leaning towards them, and facing them.

The investigators found that the pedestal systems interfered with cardiac device functioning particularly when the devices were in close proximity and lingered. Devices programmed for unipolar sensing had the most interactions which included prolonged inhibition of pacing and inappropriate ICD therapy. Devices programmed with bipolar sensing showed fewer interactions but unintentional shocks and other inappropriate tachycardia therapy was observed.

Professor Stevenson said: “Significant interactions occurred with nearly all the pacemakers and ICDs when the robot closely faced the EAS system and the device lead loop was parallel to the EAS system loop.3 Facing or having your back to an EAS pedestal or a toddler with a pacemaker crawling over a subfloor system is of particular concern.”

Wall (door frame) systems did not interfere. Preliminary tests of under floor systems (only two CIED manufacturers), which are completely hidden, did not interfere when flat or at a 30 degree angle from vertical.

Professor Stevenson said: “We know from the physics that at 90 degrees (this is when the patient’s chest is close and parallel to the floor) we would likely have serious interactions. Further testing is needed to find out when the angle becomes dangerous. I suspect it will be about 45 degrees. This angle could occur with a patient really slouching in a chair for example.”

He continued: “Unipolar sensing is sometimes required but otherwise I would urge doctors to use bipolar sensing since the lead loop area is smaller, lowering the chance of interference. Doctors must educate patients about the potential dangers of EAS systems as many have never been warned not to lean or linger in retail store entrances. It is particularly important that patients do not sit or slouch in a chair or couch in store entry areas.”

Professor Stevenson concluded: “Electronic anti-theft systems are a part of everyday life, with more than 800 000 pedestals alone installed worldwide. Patients are safe if they walk at a constant pace through the system. EAS gates that are obscured with advertising or goods for sale, or hidden in the floor with couches or chairs adjacent, are a serious concern and EAS manufacturers have a responsibility to ensure that retailers install them in such a way that they are visible and well marked.”



References and notes

1Professor Stevenson will present the abstract ‘Electronic article surveillance systems remain a potential threat to CIED patients’ during Poster session 16: ICDs which takes place on 8 June from 9:00 to 12:30 in the Poster Area.

2Unipolar pacing systems have a lead with a sensing electrode within the heart with the device forming the second electrode (which leads to a large implant loop) while bipolar systems have two closely spaced active sensing electrodes within the heart (wherein the loop is relatively small).

3When the device lead loop is parallel to the EAS system loop this invokes Faraday’s law of induction, which is when energy is transferred between circuits through electromagnetic induction. When the implant loop is large and aligned to the EAS transmitting loop antenna, coupling is maximised.

Notes to editor

ESC Press Office
Tel: +33 (0) 4 89 87 24 83


SOURCES OF FUNDING: The EAS in-vitro studies at GTRI were funded by Sensormatic, Medtronic, Boston Scientific, St. Jude Medical, Sorin and Biotronik


DISCLOSURES: Professor Robert Stevenson and Professor Roger Carrillo, MD are co-chairmen of the Cardiac Rhythm Management Device Committee of the Association for the Advancement of Medical Instrumentation (AAMI), which is also known as the US Pacemaker Committee. Robert Stevenson receives consulting and patent royalty income from Greatbatch Medical, Inc.  Roger Carrillo is a thoracic and cardiac surgeon with University of Miami Hospital – Miller School of Medicine.  Roger Carrillo is also a consultant to Spectranetics, and Tyco. Roger Carrillo is affiliated with the Medtronic, Inc. – Speaker’s bureau, St. Jude Medical Corp. – Speaker’s bureau/Research grant, and the LivaNova Group – Speaker’s bureau.



CARDIOSTIM - EHRA EUROPACE is an established, international conference attracting key opinion leaders, well-recognised scientists, physicians, allied professionals and industry.


About the European Heart Rhythm Association

The European Heart Rhythm Association (EHRA) is a registered branch of the European Society of Cardiology (ESC). Its aim is to improve the quality of life of the European population by reducing the impact of cardiac arrhythmias and reducing sudden cardiac death. EHRA promotes science and education in the field of cardiac arrhythmias with a special focus on atrial fibrillation (AF). Besides patient engagement programmes, EHRA organises scientific and educational events for physicians and allied professionals. In cooperation with other associations and societies EHRA promotes the quality of care for patients with AF with the publication of international consensus documents.


About the European Society of Cardiology

The European Society of Cardiology (ESC) represents more than 95 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.


Information for journalists attending CARDIOSTIM - EHRA EUROPACE 2016

CARDIOSTIM - EHRA EUROPACE 2016 takes place 8 to 11 June at the Nice Acropolis Convention Centre. The full scientific programme is available here To register please contact Catherine Rouillé on +33 6 73 62 57 61 or